{"product_id":"9781907673078","title":"Handbook of Osteoporosis","description":"\u003ch1\u003eHandbook of Osteoporosis\u003c\/h1\u003e\u003ch3\u003eDavid Reid\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eMedical \/ Rheumatology\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003e\n\u003cp\u003eWritten by a world-recognised expert in the field of osteoporosis, who has published extensively, and is recognized as a key opinion leader.\u003c\/p\u003e\n\u003cp\u003eAimed at primary care physicians, rheumatologists, orthopaedic surgeons, geriatricians, endocrinologists, and nurse specialists who wish to keep up to date in the prevention and management of osteoporosis\u003c\/p\u003e\n\u003cp\u003eHigh quality clinical photos and figures to enhance descriptions and aid diagnosis\u003cbr\u003eWritten by a well-known author\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003eDuring the menopause, both the quantity and quality of bone decline rapidly, leading to a dramatic increase in the risk of fracture in postmenopausal women. Although many factors are known to be associated with osteoporotic fractures, measures to identify and treat women at risk are underused in clinical practice. Consequently, osteoporosis is frequently not detected until a fracture occurs. Identification of postmenopausal women at high risk of fracture therefore is a priority.\u003c\/p\u003e\n\u003cp\u003eThe \u003ci\u003eHandbook of Osteoporosis\u003c\/i\u003e reviews the risk factors, and lifestyle changes that can help prevent osteoporosis and evaluates the pharmacological treatments currently available. \u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003c\/div\u003e\u003cdiv\u003e\n\u003cp\u003e\u003cb\u003eDavid M Reid\u003c\/b\u003e, MD, FRCPEdin, FRCPLon, holds a Personal Chair of Rheumatology at the University of Aberdeen, Scotland, UK. He is Head of the Division of Applied Medicine at the University of Aberdeen. He graduated in 1975 from the University of Aberdeen and after academic training at the University of Edinburgh returned to Aberdeen in 1983.\u003c\/p\u003e\n\u003cp\u003eHe has published over 200 original papers and reviews, largely on his current research interests which include the utility of bone mass assessment, assessment of risk of fracture, secondary osteoporosis and the assessment of long-term disease activity and drug adverse effects in rheumatic diseases.\u003c\/p\u003e\n\u003cp\u003eHe is the current chairman of the Board of Trustees of the National Osteoporosis Society (NOS) and has recently taken the lead in the NOS-endorsed guidelines on breast cancer treatment induced bone loss management.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e02 November 2011\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eSpringer Healthcare Ltd.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eSpringer Healthcare\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9781907673078\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003ePaperback softback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e131\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Springer Healthcare Ltd.","offers":[{"title":"Default Title","offer_id":53983021596812,"sku":"9781907673078","price":49.49,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9781907673078.jpg?v=1787744859","url":"https:\/\/lateknightbooks.com\/products\/9781907673078","provider":"Late Knight Books and Services, LLC","version":"1.0","type":"link"}